Bone Biologics Warrants (BBLGW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 59 87 sessions, September 16, 2025 to October 9, 2026
- Largest daily move
- +70.6% close of August 11, 2026
- 1-year change
- -25.9% closing prices, September 16, 2025 to October 9, 2026
- 1-month change
- +46.4% closing prices, September 4, 2026 to October 9, 2026
Company Description
Bone Biologics Warrants (NASDAQ: BBLGW) is classified in the orthopedic, prosthetic & surgical appliances & supplies industry.
BBLGW has declined 25.9% over the past year. The last closing price was $7.70.
For FY2025, Bone Biologics Warrants reported net income of -$3.1M and diluted earnings per share of -$2.65.
This page collects what Stock Titan holds for BBLGW, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Bone Biologics Warrants (BBLGW) closed at $7.70 on October 9, 2026. Over the past 12 months, the price has lost 25.9%.
BBLGW Metrics & Rankings
Price returns through October 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Bone Biologics Warrants has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include conferences, offering, stock split, management. View all BBLGW news →
SEC Filings
Bone Biologics Warrants has filed 10 recent SEC filings, including 4 Form 4, 3 Form 8-K, 1 Form 25-NSE, 1 Form DEF 14A. The most recent filing was submitted on October 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BBLGW SEC filings →
Financial Highlights
operating income reached -$3.2M, and net income was -$3.1M. Diluted earnings per share stood at -$2.65. The company generated -$2.7M in operating cash flow. The current ratio was 13.85, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Bone Biologics Warrants (BBLGW) currently stands at 150 shares, a new position with no short interest reported in the previous period. Since October 2025, short interest has decreased by 61.0%.
Days to Cover History
Days to cover for Bone Biologics Warrants (BBLGW) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has decreased by 99.7%. Across the settlements charted above, it has ranged from 1.0 to 385.0 days.
BBLGW Company Profile & Sector Positioning
Bone Biologics Warrants (BBLGW) and is listed on the NASDAQ.
Investors comparing BBLGW often look at related companies in the same sector, including HeartSciences Inc. Warrant (HSCSW), Ainos, Inc. Warrants (AIMDW), Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW), Spectral AI, Inc. Warrants (MDAIW), and Nexalin Technology, Inc. Warrant (NXLIW). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BBLGW's relative position within its industry.